In the current coronavirus pandemic, scientific discovery has evolved rapidly, making it more important than ever to effectively disseminate information about the biology of the virus, new methods of detection and diagnosis, as well as means of prevention and therapy of future infectious diseases. Scientific progress depends on the efficient transmission of research results to the scientific community, enabling discoveries to be assessed and extended. In this compilation of top resources, we hear from leading scientists about the latest in infectious disease diagnostics, from improved point-of-care testing and virus detection to new tools and techniques for COVID-19 research.
Dr. Christopher Mason, Associate Professor at Weill Cornell Medical College, discusses the impact of COVID-19 on his work on genetic mapping, and shares how lab automation solutions available from Tecan have assisted his SARS-CoV-2 research.
Find out more about the cell culture portfolio from PromoCell, including well-characterized and standardized human primary airway epithelial cells for SARS-CoV-2 infection studies.
Find out how the RapiDxFire™ 1-Step RT-qPCR System from LGC Biosearch Technologies can detect with a sensitive LoD, high reproducibility, and robust stability for US CDC’s 2019-nCoV signatures, including N1 and N2.
Learn how customized screen-printed electrodes (SPEs) from Metrohm Dropsens allow for rapid point-of-care testing for a range of viruses, at low costs and various configurations.
Discover the added clinical value of broad-range 16S/18S rDNA PCR from Molzym, along with sequencing analysis of culture-negative samples, and see how this impacts antimicrobial therapy selection.
Find out how the FlowCam 8000 from Yokogawa Fluid Imaging Technologies overcomes the challenges of traditional particle analysis methods by detecting micron-sized impurities and protein aggregates.
Discover a new testing workflow from Thermo Fisher Scientific designed to detect SARS-COV-2 from food packaging and the environment to decrease potential contamination and subsequent infection.
Find out more about the new bridging assay developed by LGC that detects COVID-19 in just 2 hours, increases result certainty, and is compatible with home sampling devices.
Find out more about the potentially druggable pocket within the SARS-CoV-2 Spike glycoprotein and its role in the development of new COVID-19 treatment, in this webinar from Genscript.
Other resources:
Take a look at what other researchers and scientists all over the world are saying about the latest equipment and technologies being used in coronavirus research. Nikita Delgaty, biomedical scientist at SYNLAB UK & Ireland, shared her opinion of the RAPIDPoint 500e Blood Gas System from Siemens Healthineers:
Find more news and resources in our COVID-19 & Infectious Disease Special Feature>>